Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas

NCT00337207 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00337207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00337207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
May 31, 2009
Enrollment
55 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors